Literature DB >> 29953390

Strategies to enhance NK cell function for the treatment of tumors and infections.

Jacquelyn Freund-Brown1, Leilani Chirino1, Taku Kambayashi1.   

Abstract

Natural killer (NK) cells are innate immune cells equipped with the ability to rapidly kill stressed cells that are neoplastic or virally infected. These cells are especially important in settings where these stressed cells downregulate MHC class I molecules and evade recognition by cytotoxic T cells. However, the activity of NK cells alone is often suboptimal to fully control tumor growth or to clear viral infections. Thus, the enhancement of NK cell function is necessary to fully harness their antitumor or antiviral potential. In this review, we discuss how NK cell function can be augmented by the modulation of signal transduction pathways, by the manipulation of inhibitory/activating receptors on NK cells, and by cytokine-induced activation. We also discuss how some of these strategies are currently impacting NK cells in the treatment of cancer and infections.

Entities:  

Mesh:

Year:  2018        PMID: 29953390      PMCID: PMC6343663          DOI: 10.1615/CritRevImmunol.2018025248

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  173 in total

1.  Type I IFN contributes to NK cell homeostasis, activation, and antitumor function.

Authors:  Jeremy B Swann; Yoshihiro Hayakawa; Nadeen Zerafa; Kathleen C F Sheehan; Bernadette Scott; Robert D Schreiber; Paul Hertzog; Mark J Smyth
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

Review 2.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

3.  Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.

Authors:  Lishomwa C Ndhlovu; Sandra Lopez-Vergès; Jason D Barbour; R Brad Jones; Aashish R Jha; Brian R Long; Eric C Schoeffler; Tsuyoshi Fujita; Douglas F Nixon; Lewis L Lanier
Journal:  Blood       Date:  2012-03-01       Impact factor: 22.113

4.  Dephosphorylation of the adaptor LAT and phospholipase C-γ by SHP-1 inhibits natural killer cell cytotoxicity.

Authors:  Omri Matalon; Sophia Fried; Aviad Ben-Shmuel; Maor H Pauker; Noah Joseph; Danielle Keizer; Marina Piterburg; Mira Barda-Saad
Journal:  Sci Signal       Date:  2016-05-24       Impact factor: 8.192

5.  Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma.

Authors:  Liyun Xu; Yanyan Huang; Linlin Tan; Wei Yu; Dongdong Chen; ChangChang Lu; Jianying He; Guoqing Wu; Xiaoguang Liu; Yongkui Zhang
Journal:  Int Immunopharmacol       Date:  2015-10-01       Impact factor: 4.932

6.  Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control.

Authors:  Deborah L Hodge; Alfredo Martinez; John G Julias; Lynn S Taylor; Howard A Young
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

7.  A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies.

Authors:  Tanios S Bekaii-Saab; Julie M Roda; Kristan D Guenterberg; Bhuvanaswari Ramaswamy; Donn C Young; Amy K Ferketich; Tammy A Lamb; Michael R Grever; Charles L Shapiro; William E Carson
Journal:  Mol Cancer Ther       Date:  2009-11-03       Impact factor: 6.261

8.  A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells.

Authors:  M L Lupher; K A Reedquist; S Miyake; W Y Langdon; H Band
Journal:  J Biol Chem       Date:  1996-09-27       Impact factor: 5.157

9.  Proinflammatory cytokine signaling required for the generation of natural killer cell memory.

Authors:  Joseph C Sun; Sharline Madera; Natalie A Bezman; Joshua N Beilke; Mark H Kaplan; Lewis L Lanier
Journal:  J Exp Med       Date:  2012-04-09       Impact factor: 14.307

Review 10.  Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.

Authors:  Rizwan Romee; Jeffrey W Leong; Todd A Fehniger
Journal:  Scientifica (Cairo)       Date:  2014-06-25
View more
  9 in total

1.  TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-b.

Authors:  Leilani M Chirino; Suresh Kumar; Mariko Okumura; David E Sterner; Michael Mattern; Tauseef R Butt; Taku Kambayashi
Journal:  Eur J Immunol       Date:  2019-09-30       Impact factor: 5.532

2.  Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity.

Authors:  Meisam Naeimi Kararoudi; Brian P Tullius; Nitin Chakravarti; Emily J Pomeroy; Branden S Moriarity; Kathie Beland; Aurelien B L Colamartino; Elie Haddad; Yaya Chu; Mitchell S Cairo; Dean A Lee
Journal:  Semin Hematol       Date:  2020-11-19       Impact factor: 3.851

3.  Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells.

Authors:  Zhenghu Chen; Zihua Zeng; Quanyuan Wan; Xiaohui Liu; Jianjun Qi; Youli Zu
Journal:  Biomaterials       Date:  2021-11-15       Impact factor: 12.479

Review 4.  Time to get ill: the intersection of viral infections, sex, and the X chromosome.

Authors:  Katherine S Forsyth; Montserrat C Anguera
Journal:  Curr Opin Physiol       Date:  2020-10-13

Review 5.  Nonviral genome engineering of natural killer cells.

Authors:  Gabrielle M Robbins; Minjing Wang; Emily J Pomeroy; Branden S Moriarity
Journal:  Stem Cell Res Ther       Date:  2021-06-16       Impact factor: 6.832

Review 6.  Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.

Authors:  Natasha Mupeta Kaweme; Fuling Zhou
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

7.  CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells.

Authors:  Chun-Lin Yang; Peng Zhang; Ru-Tao Liu; Na Zhang; Min Zhang; Heng Li; Tong Du; Xiao-Li Li; Ying-Chun Dou; Rui-Sheng Duan
Journal:  J Neuroinflammation       Date:  2019-12-29       Impact factor: 8.322

8.  Reovirus enhances cytotoxicity of natural killer cells against colorectal cancer via TLR3 pathway.

Authors:  Shiqi Long; Yangzhuo Gu; Yuanyuan An; Xiaojin Lin; Xiaoqing Chen; Xianyao Wang; Chunxiang Liao; Weiwei Ouyang; Nianxue Wang; Zhixu He; Xing Zhao
Journal:  J Transl Med       Date:  2021-05-01       Impact factor: 8.440

9.  Modulation of intrinsic inhibitory checkpoints using nano-carriers to unleash NK cell activity.

Authors:  Guy Biber; Batel Sabag; Anat Raiff; Aviad Ben-Shmuel; Abhishek Puthenveetil; Jennifer I C Benichou; Tammir Jubany; Moria Levy; Shiran Killner; Mira Barda-Saad
Journal:  EMBO Mol Med       Date:  2021-11-02       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.